Coccidioidomycosis

Advances in Pediatrics

Volumn 57, Issue 1, 2010, Pages 269-286

  Shehab, Ziad M ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

ADOLESCENT; AGE DISTRIBUTION; CHILD; COCCIDIOIDOMYCOSIS; ENDEMIC DISEASE; EPIDEMIC; FEMALE; HUMAN; INCIDENCE; MALE; PRESCHOOL CHILD; REVIEW; RISK ASSESSMENT; SEX RATIO; SURVIVAL RATE; UNITED STATES;

ADOLESCENT; AGE DISTRIBUTION; ANTIFUNGAL AGENTS; CHILD; CHILD, PRESCHOOL; COCCIDIOIDOMYCOSIS; DISEASE OUTBREAKS; ENDEMIC DISEASES; FEMALE; HUMANS; INCIDENCE; MALE; RISK ASSESSMENT; SEX DISTRIBUTION; SOUTHWESTERN UNITED STATES; SURVIVAL RATE;

EID: 78149372242     PISSN: 00653101     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.yapd.2010.08.008     Document Type: Review

References (94)

1. Galgiani J.N., Ampel N.M., Blair J.E., et al. Coccidioidomycosis. Clin Infect Dis 2005, 41:1217-1223.
2. Valdivia L., Nix D., Wright M., et al. Coccidioidomycosis as a common cause of community-acquired pneumonia. Emerg Infect Dis 2006, 12:958-962.
3. Kim M.M., Blair J.E., Carey E.J., et al. Coccidioidal pneumonia, Phoenix, Arizona, USA, 2000-2004. Emerg Infect Dis 2009, 15(3):397-401.
4. Posadas A. Un Nuevo caso de micosis fungoidea con posrospemias. An Cir Med Argent 1892, 15:585-597.
5. Rixford E., Gilchrist T.C. Two cases of protozoan (coccidioidal) infection of the skin and other organs. Johns Hopkins Hosp Rep 1896, 10:209-268.
6. Ophüls W., Moffitt H.C. A new pathogenic mould formerly described as a protozoan (Coccidioides immitis pyogenes): preliminary report. Philadelphia Med J 1900, 5:1471-1472.
7. Gifford M.A., Buss W.C., Douds R.J. Annual report: Kern County Department of Public Health for the fiscal year July 1, 1936 to June 30, 1937. Kern County Department of Public Health 1937, 47-52.
8. Dickson EC, Gifford MA Coccidioides infection (coccidioidomycosis). ii. The primary type of infection. Arch Intern Med 1938, 62:853-871.
9. Smith C.E. Epidemiology of acute coccidioidomycosis with erythema nodosum (" San Joaquin" or " Valley Fever" Am J Public Health 1940, 30:600-611.
10. Galgiani J.N. Coccidioidomycosis: changing perceptions and creating opportunities for its control. Ann N Y Acad Sci 2007, 1111:1-18.
11. Hirschmann J.V. The early history of coccidioidomycosis: 1892-1945. Clin Infect Dis 2007, 44:1202-1207.
12. Crum-Cianflone N.F. Coccidioidomycosis in the U.S. Military: a review. Ann N Y Acad Sci 2007, 1111:112-121.
13. Saubolle M.A., McKellar P.P., Sussland D. Epidemiologic, clinical, and diagnostic aspect of coccidioidomycosis. J Clin Microbiol 2007, 45(1):26-30.
14. Fisher M., Koenig G., White T., et al. Molecular and phenotypic description of Coccidioides posadasii sp. nov. previously recognized as the non-California population of Coccidioides immitis. Mycol Soc Am 2002, 94:73-84.
15. Barker B.M., Jewell K.A., Kroken S., et al. The population biology of Coccidioides. Epidemiologic implications for disease outbreak. Ann N Y Acad Sci 2007, 1111:147-163.
16. Fisher M., Koenig G., White T., et al. Pathogenic clones versus environmentally driven population increase: analysis of an epidemic of the human fungal pathogen Coccidioides immitis. J Clin Microbiol 2000, 38(2):807-813.
17. Comrie A.C., Glueck M.F. Assessment of climate-coccidioidomycosis model: model sensitivity for assessing climatologic effects on the risk of acquiring coccidioidomycosis. Ann N Y Acad Sci 2007, 1111:83-95.
18. Talamantes J., Behseta S., Zender C.S. Fluctuations in climate and incidence of coccidioidomycosis in Kern County, California-a review. Ann N Y Acad Sci 2007, 1111:73-82.
19. Fisher F.S., Bultman M.W., Johnson S.M., et al. Coccidioides niches and habitat parameters in the southwestern United States-a matter of scale. Ann N Y Acad Sci 2007, 1111:47-72.
20. Winn W.A., Levine H.B., Broderick J.E., et al. A localized epidemic of coccidioidal infection: Primary coccidioidomycosis occurring in a group of ten children infected in a backyard playground in the S Joaquin Valley of California. N Engl J Med 1963, 268:867-870.
21. Centers for Disease Control and Prevention Coccidioidomycosis in workers at an archeological site-Dinosaur National Monument, Utah, June-July 2001. MMWR 2001, 50:1005-1008.
22. Smith C.E., Beard R.R., Rosenberger H.G., et al. Effect of season and dust control on coccidioidomycosis. JAMA 1946, 132:833-838.
23. Centers for Disease Control and Prevention Coccidioidomycosis following the Northridge Earthquake-California, 1994. MMWR 1994, 43:164-165.
24. Sunenshine R.H., Anderson S., Erhart L., et al. Public Health surveillance for coccidioidomycosis in Arizona. Ann N Y Acad Sci 2007, 1111:96-102.
25. Centers for Disease Control and Prevention Increase in coccidioidomycosis-California 2000-2007. MMWR 2009, 58(5):105-109.
26. Larwood T.R. Coccidioidin skin testing in Kern County, California: decrease in infection rate over 58 years. Clin Infect Dis 2000, 30:612-613.
27. Kerrick S.S., Lundergan L.L., Galgiani J.N. Coccidioidomycosis at a university health service. Am Rev Respir Dis 1985, 131:100-102.
28. Richardson H.B., Anderson J.A., McKay B.M. Acute pulmonary coccidioidomycosis in children. J Pediatr 1967, 70:376-382.
29. Roberts P.L., Lisciandro R.C. A community epidemic of coccidioidomycosis. Am Rev Respir Dis 1967, 96:766-772.
30. Cohen R. Coccidioidomycosis: case studies in children. Arch Pediatr 1949, 66:241-265.
31. Christian J.R., Sarre S.G., Peers J.H., et al. Pulmonary coccidioidomycosis in a twenty-one-day-old infant. Am J Dis Child 1956, 92:66-73.
32. Hyatt H.W. Coccidioidomycosis in a 3-week-old infant. Am J Dis Child 1963, 105:93-98.
33. Sievers M.L. Disseminated coccidioidomycosis among southwestern American Indians. Am Rev Respir Dis 1974, 109:602-612.
34. Crum N.F., Lederman E.R., Stafford C.M., et al. Coccidioidomycosis: a descriptive survey of a reemerging disease. Clinical characteristics and emerging controversies. Medicine (Baltimore) 2004, 83:149-175.
35. Louie L., Ng R., Hajjeh R., et al. Influence of host genetic factors on the severity of coccidioidomycosis. Emerg Infect Dis 1999, 5:672-680.
36. Bergstrom L., Yocum D.E., Ampel N.M., et al. Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor α antagonists. Arthritis Rheum 2004, 50:1959-1966.
37. Mertz L.E., Blair J.E. Coccidioidomycosis in rheumatology patients. Incidence and potential risk factors. Ann N Y Acad Sci 2007, 1111:343-357.
38. Blair J.E. Coccidioidomycosis in patients who have undergone transplantation. Ann N Y Acad Sci 2007, 1111:365-376.
39. Ampel N.M. Coccidioidomycosis in persons infected with HIV type 1. Clin Infect Dis 2005, 41:1174-1178.
40. Galgiani J.N. Coccidioidomycosis. West J Med 1993, 159:153-171.
41. O'Brien J.J., Gilsdorf J.R. Primary cutaneous coccidioidomycosis in childhood. Pediatr Infect Dis 1986, 5:485-486.
42. DiCaudo D.J. Coccidioidomycosis: a review and update. J Am Acad Dermatol 2006, 55:929-942.
43. Gaidici A., Saubolle M.A. Transmission of coccidioidomycosis to a human via a cat bite. J Clin Microbiol 2009, 47(2):505-506.
44. Ampel N.M., Bejarano G.C., Salas S.D., et al. In vitro assessment of cellular immunity in human coccidioidomycosis: relationship between dermal hypersensitivity, lymphocyte transformation, and lymphokine production by peripheral blood mononuclear cells from healthy adults. J Infect Dis 1992, 165:710-715.
45. Cox R.A., Magee M.M. Coccidioidomycosis: host response and vaccine development. Clin Microbiol Rev 2004, 17:804-839.
46. Vinh D.C., Masannat F., Dzioba R.B., et al. Refractory disseminated coccidioidomycosis and mycobacteriosis in interferon-γ receptor 1 deficiency. Clin Infect Dis 2009, 49:e62-e65.
47. Graham A.R., Sobonya R.E., Bronnimann D.A., et al. Quantitative pathology of coccidioidomycosis in acquired immunodeficiency syndrome. Hum Pathol 1988, 19:800-806.
48. Arnold C.A., Rakheja D., Arnold M.A., et al. Unsuspected, disseminated coccidioidomycosis without maternofetal morbidity diagnosed by placental examination: case report and review of the literature. Clin Infect Dis 2008, 48:e119-e123.
49. Wack E.E., Ampel N.M., Galgiani J.N., et al. Coccidioidomycosis during pregnancy: an analysis of ten cases among 47,120 pregnancies. Chest 1988, 94:376-379.
50. Crum N.F., Ballon-Landa G. Coccidioidomycosis in pregnancy: case report and review of the literature. Am J Med 2006, 199:e11-e17.
51. Spinello I.M., Johnson R.H., Baqi S. Coccidioidomycosis and pregnancy-a review. Ann N Y Acad Sci 2007, 1111:358-364.
52. Ampel N.M. The complex immunology of human coccidioidomycosis. Ann N Y Acad Sci 2007, 1111:245-258.
53. Lopez A.M., Williams P.L., Ampel N.M. Acute pulmonary coccidioidomycosis mimicking bacterial pneumonia and septic shock: a report of two cases. Am J Med 1993, 95:236-239.
54. Arsura A.L., Bellinghausen P.L., Kilgore W.B., et al. Septic shock in coccidioidomycosis. Crit Care Med 1998, 26:62-65.
55. Chang D.C., Anderson S., Wannemuehler K., et al. Testing for coccidioidomycosis among patients with community-acquired pneumonia. Emerg Infect Dis 2008, 14(7):1053-1059.
56. Desai S.A., Minai O.A., Gordon S.M., et al. Coccidioidomycosis in non-endemic areas: a case series. Respir Med 2001, 95:305-309.
57. Tom P.F., Long T.J., Fitzpatrick S.B. Coccidioidomycosis in adolescents presenting as chest pain. J Adolesc Health Care 1987, 8:365-371.
58. Gardner S., Seilheimer D., Catlin F., et al. Subglottic coccidioidomycosis presenting with persistent stridor. Pediatrics 1980, 66:623-625.
59. Hajare S., Rakusan T.A., Kalia A., et al. Laryngeal coccidioidomycosis causing airway obstruction. Pediatr Infect Dis 1989, 8:54-56.
60. Child D.C., Newell J.D., Bjelland J.C., et al. Radiographic findings of pulmonary coccidioidomycosis in neonates and infants. Am J Roentgenol 1985, 145:261-263.
61. Greendyke W.H., Resnick D.L., Harvey W.C. The varied roentgen manifestations of primary coccidioidomycosis. Am J Roentgenol Radium Ther Nucl Med 1970, 109:491-499.
62. Lonky S.A., Catanzaro A., Moser K.M., et al. Acute coccidioidal pleural effusion. Am Rev Respir Dis 1976, 114:681-688.
63. Merchant M., Romero A.O., Libke R.D., et al. Pleural effusion in hospitalized patients with coccidioidomycosis. Respir Med 2008, 102:537-540.
64. Birsner J.W. The roentgen aspects of five hundred cases of pulmonary coccidioidomycosis. Am J Roentgenol Radium Ther Nucl Med 1954, 72:556-573.
65. Arsura E.L., Kilgore W.B. Miliary coccidioidomycosis in the immunocompetent. Chest 2000, 117:404-409.
66. Polesky A., Kirsch C.M., Snyder L.S., et al. Airway coccidioidomycosis-report of cases and review. Clin Infect Dis 1999, 28:1273-1280.
67. Bernstein D.I., Tipton J.R., Schott P.F., et al. Coccidioidomycosis in a neonate: maternal-infant transmission. J Pediatr 1981, 99:752-754.
68. Bisla R.S., Taber T.H. Coccidioidomycosis of bone and joints. Clin Orthop 1976, 121:196-204.
69. Deresinski S.C. Coccidioidomycosis of bone and joints. Coccidioidomycosis: a text 1980, 195-224. Plenum Medical, New York. D.A. Stevens (Ed.).
70. Dennis J.L., Hansen A.E. Coccidioidomycosis in children. Pediatrics 1954, 14:481-494.
71. Adam R.D., Elliott S.P., Tojlanovic M.S. The spectrum and presentation of disseminated coccidioidomycosis. Am J Med 2009, 122:770-777.
72. Bouza E., Dreyer J.S., Hewitt W.L., et al. Coccidioidal meningitis: an analysis of thirty-one cases and review of the literature. Medicine 1981, 60:139-172.
73. Johnson R.H., Einstein H.E. Coccidioidal meningitis. Clin Infect Dis 2006, 42:103-107.
74. Shehab Z.M., Britton H., Dunn J.H. Imidazole therapy of coccidioidal meningitis in children. Pediatr Infect Dis J 1988, 7:40-44.
75. Mischel P.S., Vinters H.V. Coccidioidomycosis of the central nervous system: neuropathological and vasculopathic manifestations and clinical correlates. Clin Infect Dis 1995, 20:400-405.
76. Erly W.K., Bellon R.J., Seeger J.F., et al. MR imaging of acute coccidioidal meningitis. Am J Neuroradiol 1999, 20:509-514.
77. Williams P.L., Johnson R., Pappagianis D., et al. Vasculitic and encephalitic complications associated with Coccidioides immitis infection of the central nervous system in humans: report of 10 cases and review. Clin Infect Dis 1992, 14:673-682.
78. Caudill R.G., Smith C.E., Reinarz J.A. Coccidioidal meningitis: a diagnostic challenge. Am J Med 1970, 49:360-365.
79. Arsura E.L., Johnson R., Penrose J., et al. Neuroimaging as a guide to predict outcome for patients with coccidioidal meningitis. Clin Infect Dis 2005, 40:624-627.
80. Arsura E.L., Kilgore W.B., Ratnayake S.N. Erythema nodosum in pregnant patients with coccidioidomycosis. Clin Infect Dis 1998, 27:1201-1203.
81. Bronnimann D., Adam R.D., Galgiani J.N., et al. Coccidioidomycosis in the acquired immunodeficiency syndrome. Ann Intern Med 1987, 106:372-379.
82. Masannat F.Y., Ampel N.M. Coccidioidomycosis in patients with HIV-1 infection in the era of potent antiretroviral therapy. Clin Infect Dis 2010, 50:1-7.
83. Harley W.B., Blaser M.J. Disseminated coccidioidomycosis associated with extreme eosinophilia. Clin Infect Dis 1994, 18:627-629.
84. Smith C.E., Saito M.T., Simons S.A. Pattern of 39,500 serologic tests in coccidioidomycosis. JAMA 1956, 160:546-552.
85. Pappagianis D., Zimmer D.L. Serology of coccidioidomycosis. Clin Microbiol Rev 1990, 3:247-268.
86. Smith C.E., Saito M.T., Beard R.R., et al. Serological tests in the diagnosis and prognosis of coccidioidomycosis. Am J Hyg 1950, 52:1-21.
87. Blair J.E., Currier J.T. Significance of isolated positive IgM serologic results by enzyme immunoassay for coccidioidomycosis. Mycopathologia 2008, 166:77-82.
88. Kuberski T., Myers R., Wheat L.J., et al. Diagnosis of coccidioidomycosis using cross reaction with a Histoplasma antigen. Clin Infect Dis 2007, 44:e50-e54.
89. Durkin M., Connolly P., Kuberski T., et al. Diagnosis of coccidioidomycosis with use of the Coccidioides antigen immunoassay. Clin Infect Dis 2008, 47:e69-e73.
90. Ampel N.M., Giblin A., Mourani J.P., et al. Factors and outcomes associated with the decision to treat primary pulmonary coccidioidomycosis. Clin Infect Dis 2009, 48:172-178.
91. Aleck K.A., Bartley D.L. Multiple malformations syndrome following fluconazole use in pregnancy: report of an additional patient. Am J Med Genet 1997, 72:253-256.
92. Dewsnup D.H., Galgiani J.N., Graybill J.R., et al. Is it ever safe to stop azole therapy for Coccidioides immitis meningitis?. Ann Intern Med 1996, 124:305-310.
93. Freifeld A., Proia L., Andres D., et al. Voriconazole use for endemic fungal infections. Antimicrobial Agents Chemother 2009, 53(4):1648-1651.
94. Ampel N.M. Coccidioidomycosis: a review of recent advances. Clin Chest Med 2009, 30:241-251.